Regional Business Development Managers (m/f)

Organization
LifeCodexx AG
Job Location
Jakob-Stadler-Platz 7
78467 Konstanz
Germany
Job Description

Regional Business Development Managers (m/f)
For Europe (Northern, Southern and Eastern), Asia and South America

Your central role will be to build out our business in new and existing markets by working with existing business partners and contracting with new selected business partners and help them to reach market leadership.

 Your role :

  • Identify potential business partners in new markets
  • Manage existing  business partners and maintain excellent relationship
  • Negotiate and close business deals in line with company strategy
  • Be the interface between LifeCodexx AG and Partners
  • Represent Company at congresses & events
  • Search for solutions and services that meet or predict future needs
  • Market Intelligence in the specific region(s)

 

Your Profile :

  • Degree in biological sciences and  knowledge of the NIPT market is highly desirable
  • International business experience of  3-5 years
  • Commercial aptitude and ability to solve problems
  • Presentation, strategic selling and negotiation skills
  • Excellence in communications and experience in cross-cultural relationships
  • Able to work under pressure, meet deadlines and manage priorities
  • Fluent in English (both verbal and written) is essential
  • Further languages (French,Spanish,..)  are a plus
  • Field based job requiring  extensive travelling (min. 60%)
  • You are an employee or independent contractor

 

We  offer:

Working at LifeCodexx AG means being a part of a rapidly growing international life science company with a highly motivated team that has been shaking up the field of prenatal diagnostics since 2012. Today, we are already the market leader in many European countries. We are looking forward to you!

About Our Organization

Hadquartered in Konstanz (Germany), LifeCodexx AG has been pioneering non-invasive prenatal testing (NIPT) in Europe since 2012 with the development and launch of the PrenaTest®, Europe’s first NIPT for the determination of the most common chromosomal disorders in unborn children. The test is based on next generation sequencing (NGS) technologies. Most recently, the company has developed a novel qPCR-based NIPT assay for the determination of trisomy 21. The proprietary assay will have breakthrough potential on a global scale, as it offers highest cost-efficiencies and extremely short turnaround times, while providing highest accuracies without any risk for the pregnant woman and the unborn child.

Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.

CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.

Gladys Kong writes at Fortune that her STEM background has helped her as a CEO.

Social scientists report that the image of the 'lone scientist' might be deterring US students from STEM careers.